Availability of Cord Blood Extends Allogeneic Hematopoietic Stem Cell Transplant Access to Racial and Ethnic Minorities

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 11, 2010, Pages 1541-1548

  Barker, Juliet N ^a,b   Byam, Courtney E ^a   Kernan, Nancy A ^a   Lee, Sinda S ^a   Hawke, Rebecca M ^a   Doshi, Kathleen A ^a   Wells, Deborah S ^a   Heller, Glenn ^a   Papadopoulos, Esperanza B ^a,b   Scaradavou, Andromachi ^a   Young, James W ^a,b   van den Brink, Marcel R M ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Allogeneic transplantation; Cord blood; Hematologic malignancy; Unrelated donor

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; ETHNICITY; GRAFT RECIPIENT; HODGKIN DISEASE; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; ORGAN DONOR; PRESCHOOL CHILD; PROLYMPHOCYTIC LEUKEMIA; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CELL COUNT; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; CORD BLOOD STEM CELL TRANSPLANTATION; DEMOGRAPHY; ETHNIC GROUPS; FETAL BLOOD; HEALTH SERVICES ACCESSIBILITY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LIVING DONORS; MIDDLE AGED; MINORITY GROUPS; NEW YORK CITY; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77957752908     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.08.011     Document Type: Article

References (33)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
3. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
4. Beatty P.G., Mori M., Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995, 60:778-783.
5. Confer D.L. The National Marrow Donor Program. Meeting the needs of the medically underserved. Cancer 2001, 91:274-278.
6. Kollman C., Abella E., Baitty R.L., et al. Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation 2004, 78:89-95.
7. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
8. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1995, 335:157-166.
9. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996, 88:795-802.
10. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997, 337:373-381.
11. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
12. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
13. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008, 112:4318-4327.
14. Eapen M., Rubinstein P., Zhang M.J., et al. Comparison of outcomes after transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia. Lancet 2007, 369:1947-1954.
15. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
16. Brunstein C., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after non-myeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood 2007, 110:3064-3070.
17. Barker J.N., Abboud M., Rice R.D., et al. A " no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant 2009, 15:1596-1602.
18. Ponce D., Zheng J., Gonzales A.M., et al. Disease-free survival after cord blood transplantation is not different to that after related or unrelated donor transplantation in patients with hematologic malignancies. Blood 2009, 114. Abstract 906.
19. Brunstein C.G., Gutman J.A., DeFor T.E., et al. Reduced relapse and similar progression-free survival after double umbilical cord blood transplantation (DUCBT): comparison of outcomes between sibling, unrelated adult and unrelated DUCB hematopoietic stem cell donors. Blood 2009, 114:276.
20. Rubinstein P., Rosenfield R.E., Adamson J.W., et al. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993, 81:1679-1690.
21. Gluckman E., Rocha V. Cord blood transplantation: state of the art. Haematologica 2009, 94:451-454.
22. Verneris M.R., Brunstein C.G., Barker J., et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009, 114:4293-4299.
23. Rodrigues C.A., Sanz G., Brunstein C.G., et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol 2009, 27:256-263.
24. Hurley C.K., Fernandez-Vina M., Hildebrand W.H., et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol 2007, 68:30-40.
25. Barker J.N., Krepski T.P., DeFor T.E., et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002, 8:257-260.
26. Santos F. Mayor orders NY to expand language help. NY Times 2008.
27. Mori M., Beatty P.G., Graves M., et al. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997, 64:1017-1027.
28. Mack S.J., Tu B., Lazaro A., et al. HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population. Tissue Antigens 2009, 73:17-32.
29. Confer D., Robinett P. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant 2008, 42(Suppl 1):S3-S5.
30. Beatty P.G., Boucher K.M., Mori M., et al. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol 2000, 61:834-840.
31. Querol S., Mufti G.J., Marsh S.G., et al. Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?. Haematologica 2009, 94:536-541.
32. Kurtzberg J., Cairo M.S., Fraser J.K., et al. Results of the cord blood transplantation (COBLT) study unrelated donor banking program. Transfusion 2005, 45:842-855.
33. Dehn J., Arora M., Spellman S., et al. Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match. Biol Blood Marrow Transplant 2008, 14:1334-1340.